Hepatocellular carcinoma (HCC) is the third leading cause of cancer‐related death
worldwide. In the past decades, HCC treatment has achieved great progress; however, the …

Purpose Studies reported that 5-methylcytosine (m5C) RNA transferase alters tumor
progression; however, studies of m5C-related lncRNA remain lacking. This article intends to …

Hepatocellular carcinoma (HCC) is one of the most general malignant tumors. Hypoxia is a
critical clinical characteristic and acts as a significant part in the development and cancers' …

Numerous studies have demonstrated the important roles of epigenetic modifications in
tumorigenesis, progression and prognosis. However, in hepatocellular carcinoma, the …

Background. Pancreatic cancer (PC) has a high mortality and dismal prognosis, predicting to
be the second most lethal malignancy. 5‐Methylcytosine (m5C) and long noncoding RNAs …

Background. Colorectal cancer (CRC) is the third most common tumor worldwide. Aberrant
N6‐methyladenosine (m6A) modification can influence the progress of the CRC …

Background Immune system instability and poor prognosis are the two major clinical
performance of hepatocellular carcinoma (HCC). Abnormal expression of MiR-424-5p has …

Abstract Background N6-methyladenosine (m6A) modification and long non-coding RNAs
(lncRNAs) play pivotal roles in gastric cancer (GC) progression. The emergence of …

Methylation of RNA plays an important role in cancer. Classical forms of such modifications
include N6-methyladenine (m6A), 5-methylcytosine (m5C), and N1-methyladenine (m1A) …

Abstract N7 methylguanosine (m7G) has a crucial role the development of hepatocellular
carcinoma (HCC). This study aimed to investigate the impact of the m7G methylation core …